The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
The perfect mix: recent progress in adjuvant research
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. (1997) · Nature · doi:10.1038/41131 · Cited by 5,590
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,193
Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.-M., & Hoffmann, J. A. (1996) · Cell · doi:10.1016/s0092-8674(00)80172-5 · Cited by 4,043
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888 · cited 1×
“RIG-I responds to RNA viruses, including paramyxoviruses, influenza virus and Japanese encephalitis virus, whereas MDA5 detects picornaviruse”
BackgroundOf Mice and Not Men: Differences between Mouse and Human Immunology
Mestas, J., & Hughes, C. C. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2731 · Cited by 3,822
The expanding universe of T-cell subsets: Th1, Th2 and more
Mosmann, T. R., & Sad, S. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80606-2 · Cited by 3,633
DAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794
5'-Triphosphate RNA Is the Ligand for RIG-I
Hornung, V., Ellegast, J., Kim, S., Brzózka, K., Jung, A., Kato, H., Poeck, H., Akira, S., Conzelmann, K.-K., Schlee, M., et al. (2006) · Science · doi:10.1126/science.1132505 · Cited by 2,474
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5’-phosphates
Pichlmair, A., Schulz, O., Tan, C. P., Näslund, T. I., Liljeström, P., Weber, F., & Reis e Sousa, C. (2006) · Science · doi:10.1126/science.1132998 · Cited by 2,210
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164 · cited 1×
“However, it is certainly safer to inhibit co-stimulatory pathways than to directly activate them, and the recent outcome of a trial using a super CD28-agonist (the TGN1412 antibod”
BackgroundToll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1078231 · Cited by 1,997
Harper, D. M., Franco, E. L., Wheeler, C. M., Moscicki, A.-B., Romanowski, B., Roteli-Martins, C. M., Jenkins, D., Schuind, A., Costa Clemens, S. A., & Dubin, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68439-0 · Cited by 1,632
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M.-R., Delwart, E., Sepulveda, H., Balderas, R. S., et al. (2006) · Nature Medicine · doi:10.1038/nm1482 · Cited by 1,565
Cooperation of Toll-like receptor signals in innate immune defence
Trinchieri, G., & Sher, A. (2007) · Nature Reviews Immunology · doi:10.1038/nri2038 · Cited by 1,364
Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C., & Steinman, R. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021598 · Cited by 1,306
Therapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
Inducing and expanding regulatory T cell populations by foreign antigen
Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M. C., & von Boehmer, H. (2005) · Nature Immunology · doi:10.1038/ni1265 · Cited by 1,241
Intracellular pattern recognition receptors in the host response
Meylan, E., Tschopp, J., & Karin, M. (2006) · Nature · doi:10.1038/nature04946 · Cited by 1,206
Napolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F., & Lanzavecchia, A. (2005) · Nature Immunology · doi:10.1038/ni1223 · Cited by 1,157
Toll-like receptors in systemic autoimmune disease
Marshak-Rothstein, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1957 · Cited by 1,116
Natural regulatory T cells in infectious disease
Belkaid, Y., & Rouse, B. T. (2005) · Nature Immunology · doi:10.1038/ni1181 · Cited by 1,035
Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by Lipopolysaccharide
Caramalho, I., Lopes-Carvalho, T., Ostler, D., Zelenay, S., Haury, M., & Demengeot, J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021633 · Cited by 970
Nod-like proteins in immunity, inflammation and disease
Fritz, J. H., Ferrero, R. L., Philpott, D. J., & Girardin, S. E. (2006) · Nature Immunology · doi:10.1038/ni1412 · Cited by 892
Dendritic Cells: Translating Innate to Adaptive Immunity
Steinman, R. M., & Hemmi, H. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-32636-7_2 · Cited by 844
Toll-dependent selection of microbial antigens for presentation by dendritic cells
Blander, J. M., & Medzhitov, R. (2006) · Nature · doi:10.1038/nature04596 · Cited by 840
Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F., & Lanzavecchia, A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200111)31:11<3388::aid-immu3388>3.0.co;2-q · Cited by 788
Toll-like receptor 2 controls expansion and function of regulatory T cells
Sutmuller, R. P. M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25439 · Cited by 756
Control of B-cell responses by Toll-like receptors
Pasare, C., & Medzhitov, R. (2005) · Nature · doi:10.1038/nature04267 · Cited by 752
Toll-Like Receptor 8-Mediated Reversal of CD4 + Regulatory T Cell Function
Peng, G., Guo, Z., Kiniwa, Y., Voo, K. S., Peng, W., Fu, T., Wang, D. Y., Li, Y., Wang, H. Y., & Wang, R.-F. (2005) · Science · doi:10.1126/science.1113401 · Cited by 746
Agrawal, S., Agrawal, A., Doughty, B., Gerwitz, A., Blenis, J., Van Dyke, T., & Pulendran, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.4984 · Cited by 725
Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors
Fifis, T., Gamvrellis, A., Crimeen-Irwin, B., Pietersz, G. A., Li, J., Mottram, P. L., McKenzie, I. F. C., & Plebanski, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3148 · Cited by 664
Translating Innate Immunity into Immunological Memory: Implications for Vaccine Development
Pulendran, B., & Ahmed, R. (2006) · Cell · doi:10.1016/j.cell.2006.02.019 · Cited by 625
Expanding the effector CD4 T-cell repertoire: the Th17 lineage
Harrington, L. E., Mangan, P. R., & Weaver, C. T. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.03.017 · Cited by 590
The TREM receptor family and signal integration
Klesney-Tait, J., Turnbull, I. R., & Colonna, M. (2006) · Nature Immunology · doi:10.1038/ni1411 · Cited by 589
Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
Gavin, A. L., Hoebe, K., Duong, B., Ota, T., Martin, C., Beutler, B., & Nemazee, D. (2006) · Science · doi:10.1126/science.1135299 · Cited by 581
Immunotherapy with a Ragweed–Toll-Like Receptor 9 Agonist Vaccine for Allergic Rhinitis
Creticos, P. S., Schroeder, J. T., Hamilton, R. G., Balcer-Whaley, S. L., Khattignavong, A. P., Lindblad, R., Li, H., Coffman, R., Seyfert, V., Eiden, J. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052916 · Cited by 562
Querec, T., Bennouna, S., Alkan, S., Laouar, Y., Gorden, K., Flavell, R., Akira, S., Ahmed, R., & Pulendran, B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051720 · Cited by 552
Scavenger receptors in innate immunity
Peiser, L., Mukhopadhyay, S., & Gordon, S. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00307-7 · Cited by 534
Myeloid C-type lectins in innate immunity
Robinson, M. J., Sancho, D., Slack, E. C., LeibundGut-Landmann, S., & Sousa, C. R. E. (2006) · Nature Immunology · doi:10.1038/ni1417 · Cited by 510
Toll-like receptors as adjuvant receptors
Kaisho, T., & Akira, S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(01)00182-3 · Cited by 492
Understanding the generation and function of memory T cell subsets
Lanzavecchia, A., & Sallusto, F. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.04.010 · Cited by 462
Dillon, S., Agrawal, A., Van Dyke, T., Landreth, G., McCauley, L., Koh, A., Maliszewski, C., Akira, S., & Pulendran, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4733 · Cited by 460
Toll‐like receptor stimulation as a third signal required for activation of human naive B cells
Ruprecht, C. R., & Lanzavecchia, A. (2006) · European Journal of Immunology · doi:10.1002/eji.200535744 · Cited by 436
Alonso, P. L., Sacarlal, J., Aponte, J. J., Leach, A., Macete, E., Aide, P., Sigauque, B., Milman, J., Mandomando, I., Bassat, Q., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67669-6 · Cited by 412
Targeting dendritic cells with biomaterials: developing the next generation of vaccines
Reddy, S. T., Swartz, M. A., & Hubbell, J. A. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.10.005 · Cited by 406
Synergy and Cross-Tolerance Between Toll-Like Receptor (TLR) 2- and TLR4-Mediated Signaling Pathways
Sato, S., Nomura, F., Kawai, T., Takeuchi, O., Mühlradt, P. F., Takeda, K., & Akira, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7096 · Cited by 401
Reinvigorating exhausted HIV-specific T cells via PD-1–PD-1 ligand blockade
Freeman, G. J., Wherry, E. J., Ahmed, R., & Sharpe, A. H. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061800 · Cited by 399
Toll-Dependent Control Mechanisms of CD4 T Cell Activation
Pasare, C., & Medzhitov, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.10.006 · Cited by 386
Vaccine manufacturing: challenges and solutions
Ulmer, J. B., Valley, U., & Rappuoli, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1261 · Cited by 376
Wilson, N. S., Behrens, G. M. N., Lundie, R. J., Smith, C. M., Waithman, J., Young, L., Forehan, S. P., Mount, A., Steptoe, R. J., Shortman, K. D., et al. (2006) · Nature Immunology · doi:10.1038/ni1300 · Cited by 373
Confronting Complexity: Real-World Immunodominance in Antiviral CD8+ T Cell Responses
Yewdell, J. W. (2006) · Immunity · doi:10.1016/j.immuni.2006.09.005 · Cited by 364
Fritz, J. H., Girardin, S. E., Fitting, C., Werts, C., Mengin-Lecreulx, D., Caroff, M., Cavaillon, J.-M., Philpott, D. J., & Adib-Conquy, M. (2005) · European Journal of Immunology · doi:10.1002/eji.200526286 · Cited by 358
Mechanisms of stimulation of the immune response by aluminum adjuvants
HogenEsch, H. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00169-x · Cited by 354
Bagchi, A., Herrup, E. A., Warren, H. S., Trigilio, J., Shin, H.-S., Valentine, C., & Hellman, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.1164 · Cited by 347
Roelofs, M. F., Joosten, L. A. B., Abdollahi‐Roodsaz, S., Van Lieshout, A. W. T., Sprong, T., van den Hoogen, F. H., Van Den Berg, W. B., & Radstake, T. R. D. J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21278 · Cited by 334
COOPER, C. L., DAVIS, H. L., MORRIS, M. L., EFLER, S. M., ADHAMI, M. A., KRIEG, A. M., CAMERON, D. W., & HEATHCOTE, J. (2004) · Journal of Clinical Immunology · doi:10.1007/s10875-004-6244-3 · Cited by 330
Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines
Aucouturier, J., Dupuis, L., Deville, S., Ascarateil, S., & Ganne, V (2002) · Expert Review of Vaccines · doi:10.1586/14760584.1.1.111 · Cited by 308
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants
Pizza, M., Giuliani, M. M., Fontana, M. R., Monaci, E., Douce, G., Dougan, G., Mills, K. H. G., Rappuoli, R., & Del Giudice, G. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00553-3 · Cited by 304
Drachenberg, K. J., Wheeler, A. W., Stuebner, P., & Horak, F. (2001) · Allergy · doi:10.1034/j.1398-9995.2001.056006498.x · Cited by 285
CTLA4Ig: Bridging the Basic Immunology with Clinical Application
Bluestone, J. A., St. Clair, E. W., & Turka, L. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.03.001 · Cited by 276
Wille-Reece, U., Flynn, B. J., Loré, K., Koup, R. A., Miles, A. P., Saul, A., Kedl, R. M., Mattapallil, J. J., Weiss, W. R., Roederer, M., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052433 · Cited by 275
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
Boscardin, S. B., Hafalla, J. C. R., Masilamani, R. F., Kamphorst, A. O., Zebroski, H. A., Rai, U., Morrot, A., Zavala, F., Steinman, R. M., Nussenzweig, R. S., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051639 · Cited by 269
Flacher, V., Bouschbacher, M., Verronèse, E., Massacrier, C., Sisirak, V., Berthier-Vergnes, O., de Saint-Vis, B., Caux, C., Dezutter-Dambuyant, C., Lebecque, S., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7959 · Cited by 268
Taking toll: lipid A mimetics as adjuvants and immunomodulators
Persing, D. H., Coler, R. N., Lacy, M. J., Johnson, D. A., Baldridge, J. R., Hershberg, R. M., & Reed, S. G. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02426-5 · Cited by 258
Freytag, L. C., & Clements, J. D. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.11.010 · Cited by 252
Promotion of B Cell Immune Responses via an Alum-Induced Myeloid Cell Population
Jordan, M. B., Mills, D. M., Kappler, J., Marrack, P., & Cambier, J. C. (2004) · Science · doi:10.1126/science.1089926 · Cited by 248
Zaks, K., Jordan, M., Guth, A., Sellins, K., Kedl, R., Izzo, A., Bosio, C., & Dow, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7335 · Cited by 242
Differential TLR Recognition of Leptospiral Lipid A and Lipopolysaccharide in Murine and Human Cells
Nahori, M.-A., Fournié-Amazouz, E., Que-Gewirth, N. S., Balloy, V., Chignard, M., Raetz, C. R. H., Saint Girons, I., & Werts, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.6022 · Cited by 223
Microparticles as vaccine adjuvants and delivery systems
O’Hagan, D. T., & Singh, M. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.2.269 · Cited by 214
Gorden, K. K. B., Qiu, X. X., Binsfeld, C. C. A., Vasilakos, J. P., & Alkan, S. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6584 · Cited by 203
ISCOMTM‐based vaccines: The second decade
Sanders, M. T., Brown, L. E., Deliyannis, G., & Pearse, M. J. (2005) · Immunology & Cell Biology · doi:10.1111/j.1440-1711.2005.01319.x · Cited by 166
TLR4 Is the Signaling but Not the Lipopolysaccharide Uptake Receptor
Dunzendorfer, S., Lee, H.-K., Soldau, K., & Tobias, P. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1166 · Cited by 162
IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses
Schellack, C., Prinz, K., Egyed, A., Fritz, J. H., Wittmann, B., Ginzler, M., Swatosch, G., Zauner, W., Kast, C., Akira, S., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.071 · Cited by 158
Overview of vaccine adjuvants: present and future
Hunter, R. L. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00164-0 · Cited by 157
Rimaniol, A., Gras, G. S., Verdier, F., Capel, F., Grigoriev, V. B., Porcheray, F., Sauzeat, E., Fournier, J. G., Clayette, P., Siegrist, C., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.061 · Cited by 157
Liu, T., Matsuguchi, T., Tsuboi, N., Yajima, T., & Yoshikai, Y. (2002) · Infection and Immunity · doi:10.1128/iai.70.12.6638-6645.2002 · Cited by 157
Lemesre, J.-L., Holzmüller, P., Cavaleyra, M., Bras‐Gonçalves, R., Hottin, G., & Papierok, G. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.11.061 · Cited by 154
Toll-like Receptor Recognition Regulates Immunodominance in an Antimicrobial CD4+ T Cell Response
Yarovinsky, F., Kanzler, H., Hieny, S. E., Coffman, R. L., & Sher, A. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.015 · Cited by 139
Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants
Méndez, I. Z. R., Shi, Y., HogenEsch, H., & Hem, S. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.09.039 · Cited by 136
Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease
van Heel, D. A. (2005) · Gut · doi:10.1136/gut.2005.065888 · Cited by 134
Targeting polymerised liposome vaccine carriers to intestinal M cells
Clark, M. A., Blair, H. J., Liang, L., Brey, R. N., Brayden, D. J., & Hirst, B. H. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00258-4 · Cited by 130
Invited review: MDP and other muropeptides — direct and synergistic effects on the immune system
Traub, S., von Aulock, S., Härtung, T., & Hermann, C. (2006) · Journal of Endotoxin Research · doi:10.1179/096805106x89044 · Cited by 128
Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency
Kazzaz, J., Singh, M., Ugozzoli, M., Chesko, J., Soenawan, E., & O’Hagan, D. T. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.10.010 · Cited by 120
Garçon, N., Heppner, D. G., & Cohen, J. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.2.231 · Cited by 118
Towards the rational design of Th1 adjuvants
Moingeon, P. E., Haensler, J., & Lindberg, A. A. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00193-1 · Cited by 116
New tools for antigen delivery to the MHC class I pathway
Morón, G., Dadaglio, G., & Leclerc, C. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.11.008 · Cited by 109
Ennis, F. A., Cruz, J., Jameson, J., Klein, M. H., Burt, D. S., & Thipphawong, J. (1999) · Virology · doi:10.1006/viro.1999.9765 · Cited by 109
Xie, H., Gürsel, İ., Ivins, B. E., Singh, M., O’Hagan, D. T., Ulmer, J. B., & Klinman, D. M. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.828-833.2005 · Cited by 109
Sakaguchi, S. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030012 · Cited by 102
Toll-like receptors and antibody responses
Nemazee, D. A., Gavin, A. L., Hoebe, K. H. N., & Beutler, B. (2006) · Nature · doi:10.1038/nature04875 · Cited by 97
Kumar, S., Jones, T. R., Oakley, M. S., Zheng, H., Kuppusamy, S. P., Taye, A., Krieg, A. Μ., Stowers, A. W., Kaslow, D. C., & Hoffman, S. L. (2004) · Infection and Immunity · doi:10.1128/iai.72.2.949-957.2004 · Cited by 94
Weltzin, R., Guy, B., Thomas, W. D., Giannasca, P. J., & Monath, T. P. C. (2000) · Infection and Immunity · doi:10.1128/iai.68.5.2775-2782.2000 · Cited by 92
Self-citationγδ T cells: an alternative type of professional APC
Moser, B., & Brandes, M. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.01.002 · Cited by 87
Joseph, A. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00295-5 · Cited by 82
Enhancement of Infectious Disease Vaccines Through TLR9-Dependent Recognition of CpG DNA
McCluskie, M. J., & KRIEG, A. M. (2006) · Springer eBooks · doi:10.1007/3-540-32636-7_6 · Cited by 79
Entry of microbes into the host: using M cells to break the mucosal barrier
Jones, B. D. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80091-3 · Cited by 73
Dupont, J., Altclas, J., Lepetic, A., Lombardo, M., Vázquez, V., Salgueira, C., Seigelchifer, M. A., Arndtz, N., Antunez, E., Eschen, K. B. V., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.053 · Cited by 70
NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn’s disease
Watanabe, T., Kitani, A., & Strober, W. (2005) · Gut · doi:10.1136/gut.2005.071795 · Cited by 70
Taneichi, M., Ishida, H., Kajino, K., Ogasawara, K., Tanaka, Y., Kasai, M., Mori, M., Nishida, M., Yamamura, H., Mizuguchi, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2324 · Cited by 66
Hanke, T. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69651-7 · Cited by 65
Hawkins, L. D., Ishizaka, S. T., McGuinness, P. D., Zhang, H., Gavin, W. E., Decosta, B., Meng, Z., Hu, Y., Mullarkey, M. A., Young, D. W., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.655 · Cited by 63
Co-stimulatory agonists as immunological adjuvants
Barr, T. A., Carlring, J., & HEATH, A. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.02.022 · Cited by 61
Targeted Delivery of Drugs to the Gastrointestinal Tract
Lavelle, E. C. (2001) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v18.i4.10 · Cited by 55
Yin–Yang regulation of autoimmunity by DCs
Hart, B. A. ‘., & van Kooyk, Y. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.04.006 · Cited by 51
Therapeutic vaccination in chronic hepatitis B virus carriers
Pol, S., & Michel, M. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.5.707 · Cited by 49
Immunological Foundations to the Quest for New Vaccine Adjuvants
Burdin, N., Guy, B., & Moingeon, P. E. (2004) · BioDrugs · doi:10.2165/00063030-200418020-00002 · Cited by 49
Self-citationMaturation of dendritic cells by bacterial immunomodulators
Špíšek, R., Brázová, J., Rožková, D., Zapletalova, K., Šedivá, A., & Bartůňková, J. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.006 · Cited by 49
Vajdy, M., Selby, M., Medina-Selby, A., Coit, D., Hall, J. E., Tandeske, L., Chien, D. C., Hu, C., Rosa, D., Singh, M., et al. (2006) · Journal of General Virology · doi:10.1099/vir.0.81849-0 · Cited by 49
TLR7 imidazoquinoline ligand 3M-019 is a potent adjuvant for pure protein prototype vaccines
Johnston, D., Zaidi, B., & Bystryn, J. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0262-3 · Cited by 43
Liposomes as Protein Carriers in Immunology
Leserman, L. (2004) · Journal of Liposome Research · doi:10.1081/lpr-200039198 · Cited by 37
Pattnaik, P., Shakri, A. R., Singh, S., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.09.048 · Cited by 34
OspA lipoprotein of Borrelia burgdorferi is a mucosal immunogen and adjuvant
Erdile, L. F., & Guy, B. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00295-2 · Cited by 33
Self-citationYoder, A., Wang, X., Ma, Y., Philipp, M. T., Heilbrun, M. E., Weis, J. H., Kirschning, C. J., Wooten, R. M., & Weis, J. J. (2003) · Infection and Immunity · doi:10.1128/iai.71.7.3894-3900.2003 · Cited by 33
Stewart, V. A., Walsh, D. S., McGrath, S. M., Kester, K. E., Cummings, J. F., Voss, G., Delchambre, M., Garçon, N., Cohen, J., & Heppner, D. G. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.035 · Cited by 31
Towards optimal design of second-generation immunomodulatory oligonucleotides.
Kandimalla, E. R., Yu, D. S., & Agrawal, S. (2002) · PubMed · Cited by 29
Sanchez, V., Gimenez, S., Haensler, J., Geoffroy, C., Rokbi, B., Seguin, D., Lissolo, L., Harris, B., Rizvi, F. S., Kleanthous, H., et al. (2001) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(00)00243-1 · Cited by 25
Self-citationEffect of priming on subsequent response to inactivated influenza vaccine
Potter, C. W., & Jennings, R. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00544-3 · Cited by 12
Cited by
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Fang, R. H., Hu, C.-M. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,501
Vaccine adjuvants: mechanisms and platforms
Zhao, T., Cai, Y., Jiang, Y., He, X., Wei, Y., Yu, Y., & Tian, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01557-7 · Cited by 1,020
Didierlaurent, A. M., Morel, S., Lockman, L., Giannini, S. L., Bisteau, M., Carlsen, H., Kielland, A., Vosters, O., Vanderheyde, N., Schiavetti, F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901474 · Cited by 758
Metal nanoclusters: novel probes for diagnostic and therapeutic applications
Tao, Y., Li, M., Ren, J., & Qu, X. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00607d · Cited by 736
Mechanisms of Action of Adjuvants
Awate, S., Babiuk, L. A., & Mutwiri, G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00114 · Cited by 732
Metadata
- Authors
- Guy, B.
- Venue
- Nature Reviews Microbiology
- Published
- 2007-07
- Volume
- 5
- Issue
- 7
- Pages
- 396-397
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W2083407483
- Cited by
- 620
- References
- 120
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.